Author Manuscript Published OnlineFirst on December 6, 2017; DOI: 10.1158/0008-5472.CAN-17-1357 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Mutational mechanisms that activate Wnt signaling and predict outcomes in colorectal cancer patients William Hankey1, Michael A. McIlhatton1, Kenechi Ebede2, Brian Kennedy3, Baris Hancioglu3, Jie Zhang4, Guy N. Brock3, Kun Huang4 and Joanna Groden1 ‡ 1Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210 2Department of Anesthesiology, University of Florida, Gainesville, FL 32603 3Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210 4Department of Medical and Molecular Genetics, Indiana University, School of Medicine, Indianapolis, 46202 ‡ Corresponding Author Address: 986 BRT 460 W. 12th Ave. Columbus, OH 43210. Phone: (614) 688-4301 E-mail:
[email protected] Running Title: Transcriptional changes unique to Apc-mutant colon adenomas The authors declare no potential conflicts of interest. 1 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2017 American Association for Cancer Research. Author Manuscript Published OnlineFirst on December 6, 2017; DOI: 10.1158/0008-5472.CAN-17-1357 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract APC biallelic loss-of-function mutations are the most prevalent genetic changes in colorectal tumors, but it is unknown whether these mutations phenocopy gain-of-function mutations in the CTNNB1 gene encoding ß-catenin that also activate canonical WNT signaling. Here we demonstrate that these two mutational mechanisms are not equivalent. Further, we show how differences in gene expression produced by these different mechanisms can stratify outcomes in more advanced human colorectal cancers.